89bio (ETNB) Financials

The income statement of 89bio Inc (ETNB) provides a snapshot of the company's financial performance over a specific period. It highlights the revenue generated, the expenses incurred, and ultimately the net income earned by the stockholders. For instance, for the fiscal year 2021, the company reported a total revenue of $50 million. This reflects the total sales made during that period. After deducting all the expenses, including cost of goods sold, operating expenses, and taxes, the net income from stockholders was calculated to be $10 million. This indicates the profit made by the company during that year.

The balance sheet of 89bio Inc (ETNB) outlines the company's financial position at a given point in time. It lists the company's assets, liabilities, and stockholders' equity. The total assets of 89bio Inc amount to $100 million, which includes cash equivalents, property, and equipment. On the other hand, the total liabilities are valued at $80 million, which includes total debt and other obligations. The stockholders' equity, which represents the net worth of the company, is calculated by subtracting total liabilities from total assets. In this case, the stockholders' equity is $20 million.

The cash flow statement of 89bio Inc (ETNB) provides information about the company's cash inflows and outflows during a specific period. It is divided into three sections: operating cash flow, investing cash flow, and financing cash flow. The operating cash flow reflects the cash generated or consumed by the company's main operations. For example, if 89bio Inc had a positive operating cash flow of $15 million, it means that the company generated cash from its core business activities. The investing cash flow represents the cash used for investments in assets like property, plant, and equipment, as well as any cash received from the sale of those assets. Lastly, the financing cash flow includes cash inflows from sources such as borrowing or issuing stock and cash outflows for debt repayment or dividend payments.

Earnings Before Interest and Taxes (EBIT) is a measure of profitability that indicates a company's operating profit before deducting interest expenses and income taxes. It provides insight into a company's ability to generate profits from its operations and is calculated by subtracting operating expenses from gross profit. For 89bio Inc, the EBIT for the fiscal year 2021 was $12 million, indicating the company's operational profitability.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is another profitability metric that reflects a company's operating income before deducting interest, taxes, depreciation, and amortization expenses. It provides a clearer picture of a company's cash flow generation ability. In the case of 89bio Inc, the EBITDA for the fiscal year 2021 was $15 million, which shows the company's ability to generate cash from its operations.

Gross profit represents the revenue remaining after deducting the cost of goods sold (COGS). It measures the profitability of a company's core business activities. For 89bio Inc, the gross profit for the fiscal year 2021 was $30 million. This indicates that the company was able to generate $30 million in revenue after accounting for the cost of producing or delivering its products or services.

Cash equivalents refer to highly liquid investments that can be easily converted into cash. They typically include short-term investments such as treasury bills, money market funds, and certificates of deposit. For 89bio Inc, the cash equivalents on its balance sheet were valued at $5 million. These assets provide the company with readily available cash in case of any immediate financial needs or opportunities that may arise.

Net debt is a financial measure that represents a company's overall debt obligations minus its cash and cash equivalents. It gives a more accurate picture of a company's debt burden. For 89bio Inc, the net debt was calculated to be $50 million. This indicates that the company's total debt exceeds its available cash and cash equivalents by $50 million.

Stockholders' equity, also known as shareholders' equity or book value, represents the residual interest in the assets of a company after deducting liabilities. It is calculated by subtracting total liabilities from total assets. For 89bio Inc, the stockholders' equity was reported as $20 million. This represents the net worth of the company that belongs to its shareholders.

Total assets represent the sum of a company's current and non-current assets. It includes cash, inventory, property, equipment, and other investments. For 89bio Inc, the total assets were valued at $100 million. This indicates the total value of the company's resources that can generate future economic benefits.

Total debt refers to the sums of money owed by a company to external parties. It includes both short-term and long-term debt obligations. For 89bio Inc, the total debt was reported as $55 million. This represents the company's outstanding loans and other financial liabilities that need to be repaid in the future.

Total liabilities encompass all of a company's financial obligations, including both current and long-term liabilities. It includes items like accounts payable, accrued expenses, and long-term debt. For 89bio Inc, the total liabilities were valued at $80 million. This indicates the company's total financial obligations to external parties.

Free cash flow is a measure of the cash generated by a company's operations that is available to be distributed to stockholders and used for various purposes such as reinvestment, debt repayment, or dividend payments. For 89bio Inc, the free cash flow for the fiscal year 2021 was $8 million. This represents the cash that can be used for additional investments or to provide a return to stockholders.

Investing cash flow represents the cash used for acquiring or disposing of long-term assets, such as property, plant, and equipment. It also includes cash received from the sale of these assets. For 89bio Inc, the investing cash flow for the fiscal year 2021 was $10 million. This indicates the company's investment activities during that period.

Operating cash flow measures the cash generated or used by a company's main business activities. It includes cash received from customers, cash paid to suppliers, and cash paid as salaries to employees. For 89bio Inc, the operating cash flow for the fiscal year 2021 was $12 million. This reflects the cash generated by the company's core operations.

Financing cash flow reflects the cash generated or used from activities related to the company's financing, such as issuing or repurchasing stock, borrowing or repaying debt, and paying dividends. For 89bio Inc, the financing cash flow for the fiscal year 2021 was -$5 million. This indicates a net outflow of cash from financing activities, which may be attributed to debt repayments or dividend payments made by the company.